NHLBI Catalyze R33 — Medical Device Prototype Optimization (no clinical trials)
This NHLBI Catalyze R33 supports late-stage prototype optimization for medical devices, diagnostic assays, and research tools targeting heart, lung, blood, and sleep (HLBS) diseases; clinical trials are not allowed. Applicants must have an Accelerator Partner, provide non‑federal matching funds (recommended ≥0.25:1), submit preliminary IP and regulatory strategies, and propose milestone-driven…
Source
Award
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
Get the full picture on this opportunity
Create a free Scout account to unlock everything you need to decide fast and win the grant.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Deep agency & funder detail
Program context, sub-agency structure, and a full eligibility breakdown.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Similar opportunities
Discover related funding matched to your work.
Already have an account? Sign In
Trusted by 500+ Happy Customers